Cmpx stock forecast.

4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.Tutorial video for Capsim business simulation. In this video, I take you on a step-by-step demonstration on how you can do Forecasting, Marketing, and Produc...Get the latest CompX International Inc. (CIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Comprehensive selection of real-time charts, which plot movements in the forex, futures and stock markets, with quotes updated continuously throughout the trading day.

Aeterna Zentaris (TSE:AEZS) Forecast: Is this specialty biopharmaceutical company a good stock to buy? Find out the latest analysis, ratings, and price targets from TipRanks, the leading platform for financial insights.Look out for CMPX's next earnings release expected on November 08, 2023. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year ... Abstract. Biogenic secondary organic aerosols (SOAs) contribute to a large fraction of fine aerosols globally, impacting air quality and climate. The formation of biogenic SOA depends on not only emissions of biogenic volatile organic compounds (BVOCs) but also anthropogenic pollutants including primary organic aerosol, sulfur dioxide (SO2), and …

CMPX: Compass Therapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Compass Therapeutics, Inc. from Zacks Investment Research

From AI system, total return is 2366.52% from 4098 forecasts. For CompX International stock forecast for 2023, 1 predictions are offered for each month of 2023 with average CompX International stock forecast of $20.52, a high forecTutorial video for Capsim business simulation. In this video, I take you on a step-by-step demonstration on how you can do Forecasting, Marketing, and Produc...CMPX Stock 12 Months Forecast. $10.50. (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a high forecast of $11.00 and a low forecast of $10.00. The average price target represents a 510.47% change from the last price of $1.72. Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment ratingNov 15, 2023 · The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts

NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes

Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of …

Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business.Abstract. Biogenic secondary organic aerosols (SOAs) contribute to a large fraction of fine aerosols globally, impacting air quality and climate. The formation of biogenic SOA depends on not only emissions of biogenic volatile organic compounds (BVOCs) but also anthropogenic pollutants including primary organic aerosol, sulfur dioxide (SO2), …The average Mind Medicine stock price prediction forecasts a potential upside of 810.6% from the current MNMD share price of $3.02. What is MNMD's forecast return on equity (ROE) for 2023-2026? (NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.The value each CMPX share was expected to gain vs. the value that each CMPX share actually gained. Compass Therapeutics ( CMPX) reported Q2 2023 earnings per share (EPS) of -$0.09, missing estimates of -$0.08 by 9.30%. In the same quarter last year, Compass Therapeutics 's earnings per share (EPS) was -$0.08. Compass Therapeutics is expected to ...Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price.

Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast.Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesAccording to the issued ratings of 1 analysts in the last year, the consensus rating for Kamada stock is Buy based on the current 1 buy rating for KMDA. The average twelve-month price prediction for Kamada is $11.00 with a high price target of $11.00 and a low price target of $11.00. Learn more on KMDA's analyst rating history.4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.

Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information. What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast.Compass Therapeutics, Inc. - Hold. Zacks' proprietary data indicates that Compass Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CMPX shares ...KNTE Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Kinnate Biopharma in the last 3 months. The average price target is $2.70 with a high forecast of $4.00 and a low forecast of $1.50. The average price target represents a 20.00% change from the last price of $2.25.Compass Therapeutics. Compass Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Its pipeline product candidates are CTX-471/ CD137 agonist and CTX-8371.The Compx International, Inc. - Class A stock forecast is 40.29786370896 USD for 2024 November 25, Monday; and 148.757 USD for 2028 November 25, Saturday with technical analysis. Compx International, Inc. - Class A (CIX) stock price prediction is 40.29786370896 USD.Webull provides a variety of real-time CMPX stock news. You can receive the latest news about Compass Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions. About CMPX. Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is focused on …The average one-year price target for CMPX / Compass Therapeutics Inc is $9.35. The forecasts range from a low of $8.08 to a high of $11.55. A stock’s price target is the price at which analysts consider it fairly valued with respect to …

The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors?

Compass Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction. ... CMPX Related stocks. Symbol 3M %Chg ; CMPX +4.67% : Compass Therapeutics ...

CMPX Overview Stock Screener Earnings Calendar Sectors Nasdaq | CMPX U.S.: Nasdaq Compass Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Oct 13, 2023 4:38... Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast.Compass Therapeutics Inc (CMPX) Reports Q3 2023 Financial Results and Corporate Developments. Get the latest Compass Therapeutics, Inc. (CMPX) stock news and headlines to help you in your trading ...SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...Find the latest Compass Therapeutics, Inc. (CMPX) stock forecast, 12-month price target, predictions and analyst recommendations.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.The Eterna Therapeutics 52-week low stock price is 0.84, which is 31.1% below the current share price. ... Compass Therapeutics (CMPX), United States, $0.215B ...Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Compass Therapeutics Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Compass Therapeutics Inc. (CMPX ...PAYO Stock 12 Months Forecast. $8.80. (56.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Payoneer in the last 3 months. The average price target is $8.80 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 56.58% change from the last price of $5.62.Get the latest news and real-time alerts from Compass Therapeutics, Inc. (CMPX) stock at Seeking Alpha. ... CMPX Compass Therapeutics, Inc. Latest News. Follow $1.93 0.00 (0.00%) ...

Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST... Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ...FORECASTS Analyst Sentiment LeaderboardLCTX is expected to report earnings to rise 3.50% to -4 cents per share on March 14. The last earnings report on November 09 showed earnings per share of -3 cents, beating the estimate of -5 cents. With 284.08K shares outstanding, the current market capitalization sits at 169.46M.Instagram:https://instagram. best whole life insurance cash valuealbany ny financial advisorsglobalstar.top vision insurance BHC Stock 12 Months Forecast. $9.00. (30.72% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $9.00 with a high forecast of $16.00 and a low forecast of $6.00. The average price target represents a 30.72% change from the last price of $6.89.Most recent stock forecast was given on BGNE, BeiGene, Ltd at 26-Jun-2023 ... CMPX GLUE TNGX TPTX Turning Point Therapeutics NRIX Nurix Therapeutics COGT ... 1979 silver dollar susan b anthonyinfeneon Oct 2, 2023 · Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum. cls investments Prev Close 2.81. 52 Week High 5.65. 52 Week High Date 12/23/22. 52 Week Low 1.30. 52 Week Low Date 05/04/22. Market Cap 380.788M. Shares Out 126.51M. 10 Day Average Volume 0.28M. Dividend -.